← Back to Search

Exercise for PCOS & Insulin Resistance

N/A
Waitlist Available
Led By Heather Huddleston, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 weeks, 8 weeks
Awards & highlights

Study Summary

This trial will test if a structured exercise program can help improve insulin resistance in women with polycystic ovary syndrome.

Eligible Conditions
  • Insulin Resistance
  • Polycystic Ovary Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 weeks, 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 weeks, 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Completed Days of Exercise
Drop-out Rate
Secondary outcome measures
Androgens (Change in free/total testosterone)
Fasting Insulin
HDL Cholesterol
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Vigorous ExerciseExperimental Treatment1 Intervention
High-intensity interval training for 15 minutes daily, 5 days per week for 8 weeks
Group II: Moderate ExerciseExperimental Treatment1 Intervention
Brisk walking for 30 minutes daily, 5 days per week for 8 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vigorous Exercise
2012
N/A
~150
Moderate Exercise
2019
N/A
~140

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,503 Previous Clinical Trials
15,236,608 Total Patients Enrolled
17 Trials studying Insulin Resistance
1,630 Patients Enrolled for Insulin Resistance
Heather Huddleston, MDPrincipal InvestigatorUniversity of California, San Francisco
6 Previous Clinical Trials
8,280 Total Patients Enrolled
1 Trials studying Insulin Resistance
5 Patients Enrolled for Insulin Resistance

Media Library

Moderate Exercise Clinical Trial Eligibility Overview. Trial Name: NCT02303470 — N/A
Insulin Resistance Research Study Groups: Vigorous Exercise, Moderate Exercise
Insulin Resistance Clinical Trial 2023: Moderate Exercise Highlights & Side Effects. Trial Name: NCT02303470 — N/A
Moderate Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT02303470 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do any openings remain available to join this clinical research experiment?

"Confirmed, this clinical trial is not currently enrolling patients. Initially posted on March 1st 2015 and last updated December 1st 2022, it has since been closed off to new candidates. Thankfully, there are an abundance of alternative medical studies with open enrollment at this time - 1584 in total."

Answered by AI

What characteristics make a participant suitable for this research endeavor?

"This research trial is enrolling 47 people with sclerocystic ovaries, aged between 18 and 50. Eligibility requirements are thus quite narrow."

Answered by AI

What are the fundamental goals of this experiment?

"This 8-week clinical trial is designed to measure the Dropout Rate. In addition, researchers will track changes in Fasting Insulin levels, psychological effects as observed through Beck Depression Inventory - Fast Screen results, and modifications of HDL Cholesterol concentrations."

Answered by AI

Is the eligibility criteria of this experiment inclusive of those over 45 years old?

"This clinical trial only permits participation from individuals aged 18-50. Significantly, there are 412 studies designed for younger people and 1076 trials targeting elderly demographics."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
What portion of applicants met pre-screening criteria?
Did not meet criteria
~5 spots leftby Apr 2025